Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117)

Potential use of imatinib mesylate in ocular melanoma and liposarcoma expressing immunohistochemical c-KIT (CD117)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 14; no. 5; p. 805
Main Authors: Fiorentini, G., Rossi, S., Lanzanova, G., Bernardeschi, P., Dentico, P., De Giorgi, U.
Format: Journal Article
Language:English
Published: England Oxford University Press 01-05-2003
Subjects:
Adult
Aged
Benzamides
Eye Neoplasms - drug therapy
Eye Neoplasms - metabolism
Female
Humans
Imatinib Mesylate
Immunohistochemistry
Liposarcoma - drug therapy
Liposarcoma - metabolism
Male
Melanoma - drug therapy
Melanoma - metabolism
Middle Aged
Piperazines - therapeutic use
Proto-Oncogene Proteins c-kit - biosynthesis
Pyrimidines - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:local:mdg192
E-mail: oncologiaempoli@usl11.toscana.it
ark:/67375/HXZ-HQT0SHQ8-N
istex:96E920D20FAB4BC46D4BE4EF6C67B18B70035EB2
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdg192